Tressa D. Randall

Statistics

Publications

Citations

107

H-Index

Active since

2014

Affiliations

Translational Genomics Research Institute(Current)

Tressa D. Randall is an author at Translational Genomics Research Institute specializing in pharmacology, safety and tolerability, and antitumor t cell responses.

Publications per year

2014–2015

Publications

A Phase I Dose-Finding Study of the Novel Toll-like Receptor 8 Agonist VTX-2337 in Adult Subjects with Advanced Solid Tumors or Lymphoma

Donald W. Northfelt, Ramesh K. Ramanathan, Peter A. Cohen et al. · Clinical Cancer Research · 2014 · 68 citations

Medicine, Oncology, Pharmacology +16

Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337)

Gregory N. Dietsch, Tressa D. Randall, Raphaël Gottardo et al. · Clinical Cancer Research · 2015 · 39 citations

Life Sciences, Immunology, Pharmacology +17

1–2 of 2